Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

ReNeuron Group PLC

LON:RENE

ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.

298 stories · page 6 of 15

Investments and investor services

AorTech in good heart

A look at the day's major movers, including Tri-Star Resources, Quixant, Metals Exploration, NCC Group, Primary Health Properties, MedicX Fund, Nautical Marine Services, Blue Star Capital and Gama Aviation.

By Proactive